Position in REPL
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$4,934
+$744 QoQ
Shares Held
645
-35.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Hurley Capital, LLC holds $43,993 across 16 Biotechnology names. REPL ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SANA |
Sana Biotechnology, Inc.
|
2,000 | $5,760 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
206 | $5,706 | |
| 3 | REPL |
Replimune Group, Inc.
This page
|
645 | $4,934 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
120 | $4,059 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
100 | $4,031 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
80 | $3,805 | |
| 7 | CRDF |
Cardiff Oncology, Inc.
|
2,100 | $3,402 | |
| 8 | MRNA |
Moderna, Inc.
|
64 | $3,251 |
All Filings in REPL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,934 | 645 | Shares | Sole | 2026-05-06 | |
| 2025-09-30 | $4,190 | 1,000 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||